U.S. Pharma Stock News

Flexsteel Industries (FLXS) has just posted its latest numbers, with recent quarterly revenue at about US$118.2 million and basic EPS of roughly US$1.24, set against trailing 12 month revenue of US$457.3 million and EPS of US$3.95 that also reflect a one off loss of US$9.6 million in the period. Over recent quarters, revenue has moved from US$104.0 million in early 2025 to US$118.2 million in the latest reported quarter. Quarterly EPS has ranged from US$0.80 to US$2.03 across that stretch,...

Mercantile Bank (MBWM) just posted another quarter of steady profitability, with Q4 2025 revenue at US$61.8 million and net income of US$22.8 million, which translates into basic EPS of US$1.40 ahead of its Q1 2026 reporting period. Over recent quarters the bank has seen revenue move from US$56.3 million in Q4 2024 to US$61.8 million in Q4 2025, while basic EPS increased from US$1.22 to US$1.40, giving investors a clear picture of consistent earnings power heading into the new year. With...

NETSTREIT (NTST) has kicked off its Q1 2026 reporting cycle with investors looking back at a steady run of quarterly numbers, including Q4 2025 revenue of US$52.7 million and basic EPS of US$0.02, supported by the REIT focused measure of Funds From Operations of US$26.6 million. Over the past year, the company has seen revenue move from US$44.1 million in Q4 2024 to US$52.7 million in Q4 2025, while basic EPS shifted from a loss of US$0.07 to a modest profit of US$0.02. This sets the backdrop...

Vicor (VICR) has reported a strong set of numbers heading into its Q1 2026 update, with Q4 2025 revenue of US$107.3 million, basic EPS of US$1.03 and trailing 12 month net income of US$118.6 million on revenue of US$407.7 million. This was accompanied by very strong year over year earnings growth that includes a one off gain of US$37.5 million. Over the last few quarters, revenue has moved from US$93.2 million in Q3 2024 to US$96.2 million in Q4 2024 and then to US$107.3 million in Q4 2025...

AbCellera Biologics recently announced that it will share interim Phase 1 data for ABCL635, its potential first-in-class non-hormonal antibody targeting the neurokinin 3 receptor for menopausal vasomotor symptoms, during its first-quarter 2026 earnings call on May 11, 2026. This update marks the first clinical readout from AbCellera’s GPCR and ion channel platform, highlighting how its transition into a clinical-stage pipeline is beginning to be tested in humans. We’ll now examine how the...

POET Technologies recently addressed a short report about U.S. tax complications linked to its passive foreign investment company status and outlined plans, including a potential U.S. headquarters move, to ease the burden on American shareholders. At the same time, the company reported audited Q4 2025 results showing a shift from development to execution, supported by over US$375.00 million of fresh financing and growing commercialization of its optical solutions for AI and hyperscale data...

In April 2026, Zymeworks Inc. presented six sets of new preclinical data at the AACR Annual Meeting, highlighting progress across its antibody-drug conjugate and novel payload programs targeting RAS-mutant and other hard-to-treat cancers. The breadth of first-in-class ADC constructs and new payload classes, including pan-RAS and mRNA translation inhibitors, underscores Zymeworks’ ambition to build a differentiated oncology technology stack rather than rely on a single lead asset. We’ll now...

Parker-Hannifin recently reported its third-quarter results, with Wall Street having expected diluted EPS of $7.81, an increase of 12.5% from $6.94 a year earlier. Investor attention is heightened because the company has outpaced consensus EPS forecasts in each of the previous four quarters, raising interest in whether that pattern can continue. Next, we will examine how expectations for double-digit EPS growth this quarter affect Parker-Hannifin’s broader investment narrative and long-term...

Recent performance snapshot American Electric Power Company (AEP) has drawn fresh attention after recent share price moves, with the stock showing a month return of 6.1% and a past 3 months return of 11.8%. Over longer periods, total returns stand at 15.1% year to date, 30.5% over the past year, 58.3% over three years, and 82.5% over five years, all in US$ terms. See our latest analysis for American Electric Power Company. With the latest share price at US$133.28 and a 30 day share price...

Recent performance snapshot Acadia Healthcare Company (ACHC) has drawn attention after a recent share price move, with the stock closing at $27.84 and posting gains over the past week, month and past 3 months. See our latest analysis for Acadia Healthcare Company. The recent 1 day share price return of 3.11% sits within a strong run, with a 30 day share price return of 22.48% and a 90 day share price return of 95.51%. However, the 3 year total shareholder return of negative 62.31% shows that...

What Toll Brothers’ recent returns tell you Toll Brothers (TOL) has drawn attention after an 11.6% move over the past month, adding to a 61.1% total return over the past year and 151.3% over five years. With a market value of about US$13.9b, Toll Brothers generates US$11.3b in revenue and US$1.4b in net income. This positions it as a large US luxury homebuilder with nationwide exposure across several regional segments. See our latest analysis for Toll Brothers. That recent 11.6% 1 month share...

In April 2026, Prologis reported first-quarter 2026 results showing sales of US$2,125.08 million, revenue of US$2,297.72 million, and net income of US$981.98 million, while also raising its full-year 2026 net earnings guidance range for common stockholders to US$3.80–US$4.05 per share. Alongside these results, Prologis deepened its global logistics footprint through the planned Prologis Logistics Investment Venture Europe with La Caisse and highlighted growing data center ambitions with new...

Axsome Therapeutics recently attracted attention after Oppenheimer highlighted an “attractive setup” around the now-past US FDA priority review decision on expanding Auvelity’s label to include Alzheimer’s disease agitation. The broker emphasized Auvelity’s differentiated safety profile and potential for longer-term use, arguing these features could support advantageous formulary positioning versus competing treatments. Next, we’ll examine how expectations around the Alzheimer’s agitation...

Fidelis Insurance Holdings Ltd. recently completed the early redemption of its 6.625% Fixed-Rate Junior Notes due April 1, 2041, leading to their de-listing from the Bermuda Stock Exchange effective April 8, 2026, under Regulation 6.17 (3). This early redemption highlights an active reshaping of Fidelis’s capital structure, which may influence how investors assess its balance sheet flexibility and funding mix. We’ll now examine how Fidelis’s early redemption and de-listing of junior notes...

In April 2026, Proto Labs launched ProDesk by Protolabs, an upgraded e-commerce platform that offers real-time AI-powered quoting, design-for-manufacturability analysis, and collaboration tools aimed at accelerating aerospace product development from prototyping through production. This move highlights Proto Labs’ push to embed AI deeper into its digital manufacturing workflow, potentially making it a more integral partner for aerospace and other complex, regulated industries. Next, we’ll...

Alpha and Omega Semiconductor recently celebrated the inauguration of Kaynes Semicon’s OSAT facility in Sanand, Gujarat, where its proprietary IPM5 manufacturing process is now in high-volume production for global power semiconductor customers. By bringing advanced packaging and testing capabilities online in just 14 months, the collaboration deepens Alpha and Omega Semiconductor’s manufacturing presence in India while supporting the India Semiconductor Mission’s goal of building...

Recent commentary on MYR Group highlights concern that its sales pipeline and average backlog growth of 5.4% over the past two years may not support earlier revenue growth expectations. With a forward P/E ratio of 34.2x, MYR Group’s weaker gross margin of 10.8% and waning returns on capital are drawing attention to potential profitability pressure. Next, we’ll examine how concerns about MYR Group’s slower backlog growth may reshape its previously measured, contract-driven investment...

Four Corners Property Trust recently acquired a National Veterinary Associates property in a strong California retail corridor for US$4,400,000 under a long-term, net lease at a 7.1% cap rate, excluding transaction costs. This veterinary asset adds an essential service tenant to FCPT’s portfolio, underscoring its shift toward more resilient, non-restaurant income streams. Next, we’ll examine how adding a long-term, net-leased veterinary property may influence Four Corners Property Trust’s...

Earlier in April 2026, Baxter International showcased new additions to its Global Surgical Solutions and Patient Support Systems portfolios at the AORN Global Surgical Conference, including the AAT XR spine surgical table and Dynamo Series smart stretcher, while also highlighting its Advanced Surgery hemostatic and sealing agents. The combination of workflow-focused surgical equipment and connected patient support solutions underlines Baxter’s emphasis on easing staff strain and improving...

Annaly Capital Management, Inc. reported that it would release its Q1 2026 results after the market close at 4:00 p.m. US Eastern Time on April 21, 2026, following several quarters of positive economic returns, portfolio growth and capital raising activity across Agency MBS, residential credit and mortgage servicing rights. The combination of sustained positive economic returns and management’s confidence in Agency MBS fundamentals, alongside expanding MSR and residential credit exposure,...

Fermi Inc. recently reshaped its leadership and governance, with co-founder Toby Neugebauer stepping down as CEO, Miles Everson resigning as CFO to join the board, the creation of an interim Office of the CEO led by Co-Presidents Jacobo Ortiz Blanes and Anna Bofa, and the appointment of Jeffrey S. Stein as a new director, while also committing to new headquarters in Dallas and expanded offices at Project Matador in Amarillo. Together, these moves mark a shift from founder-led management to a...

Sensient Technologies recently announced it will invest up to US$250,000,000 to expand natural color production, adding 28,800 square feet at its St. Louis plant to meet rising reformulation demand from food manufacturers. Management has described the shift to natural colors as the largest opportunity in the company’s history, signaling a meaningful scale-up of its clean-label ingredients focus. We’ll now examine how Sensient’s US$250,000,000 natural color capacity expansion could reshape...

Earlier this month, Coherent Corp. announced advances in its silicon carbide epitaxy platforms for 150mm and 200mm wafers, supporting power devices up to and beyond 10kV for AI datacenters and industrial electrification across renewables, rail, fast charging, and grid infrastructure. This progress strengthens Coherent’s position across the silicon carbide value chain, allowing customers to design more compact, energy-efficient, high-voltage power systems that can meet demanding reliability...

Wolfe Research has identified Trex Company (TREX) as a preferred name in building products, citing relatively lower inflationary risk at a time when peers are dealing with soft demand and rising input costs. See our latest analysis for Trex Company. Recent momentum has been strong, with a 20.89% 1 month share price return and 21.43% year to date share price return, even as the 1 year total shareholder return shows an 18.92% decline. If Trex’s recent move has you thinking about what else could...